Jan-hendrik Bockmann
Hamburg, HH, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Ten-Year Follow-Up After 96 Weeks Treatment With Peginterferon Plus Tenofovir in Hepatitis D (HIDIT-II): Improved Clinical Outcome After Combination Therapy.
Journal: United European gastroenterology journal
Published: October 21, 2025
Hepatitis D virus infection triggers CXCL9-11 upregulation in hepatocytes and liver infiltration of CXCR3+ CD4 T cells.
Journal: JHEP reports : innovation in hepatology
Published: January 19, 2024
Non-organ-specific autoantibodies with unspecific patterns are a frequent para-infectious feature of chronic hepatitis D.
Journal: Frontiers in medicine
Published: February 18, 2023
Clinical establishment of a laboratory developed quantitative HDV PCR assay on the cobas6800 high-throughput system.
Journal: JHEP reports : innovation in hepatology
Published: May 04, 2021
High Rates of Liver Cirrhosis and Hepatocellular Carcinoma in Chronic Hepatitis B Patients with Metabolic and Cardiovascular Comorbidities.
Journal: Microorganisms
Published: April 07, 2021
Comparative Analysis of the Antiviral Effects Mediated by Type I and III Interferons in Hepatitis B Virus-Infected Hepatocytes.
Journal: The Journal of infectious diseases
Published: October 21, 2018
High rates of cirrhosis and severe clinical events in patients with HBV/HDV co-infection: longitudinal analysis of a German cohort.
Journal: BMC gastroenterology
Published: October 08, 2018
Hepatitis B Virus Activates Signal Transducer and Activator of Transcription 3 Supporting Hepatocyte Survival and Virus Replication.
Journal: Cellular and molecular gastroenterology and hepatology
Published: December 04, 2016
The challenge of protecting without overprotecting: The two sides of myeloid-derived suppressor cells in hepatitis B viral infection.
Journal: Hepatology (Baltimore, Md.)
Published: October 15, 2015
Last Updated: 09/26/2026